Breaking News

Daily Archives: March 24, 2016

Board meeting of Pakistan Reinsurance Company Limited will be held on April 05, 2016

Karachi: Pakistan Reinsurance Company Limited informed Pakistan Stock Exchange that board of directors meeting of the company will be held on April 05, 2016 at Karachi. The agenda of the meeting is to consider Annual Accounts for year ended December 31, 2015. Further, the Company has declared the closed period from April 23, 2016 to April 30, 2016. Pakistan Reinsurance Company Limited was formerly referred to as Pakistan Insurance Corporation established in 1952 under PIC Act, 1952 for supporting the local insurance company. On March 30, 2000 the company was incorporated as a public limited company under the Companies Ordinance, 1984. The company ensures the development of insurance and reinsurance business in Pakistan. The registered office of the company is located in Karachi. The shares of the company are quoted on the Karachi and Lahore Stock Exchanges of Pakistan. The company operates in the public sector under the administrative control of the Ministry of Commerce. The functions of the company include providing insurance solutions to departments including aviation, marine cargo, marine hull, engineering, fire and accident. The company also provides reinsurance protection to the local insurance industry in view of treaty and facultative business as well as managing insurance schemes assigned by the Federal Government of Pakistan. The insurance market holds 18% of the share whereas 45% of the share is covered by the reinsurance protection in Pakistan. The symbol “PAKRI” is being used by the stock exchange for the shares of Pakistan Reinsurance Company Limited.

Read More »

Board meeting of Glaxosmithkline Pakistan Limited to be held on March 30, 2016

Karachi: Glaxosmithkline Pakistan Limited informed Pakistan Stock Exchange that board of directors meeting of the company will be held on March 30, 2016 at Karachi. The agenda of the meeting is to consider Financial Results of the company for year ended December 31, 2015. Further, the Company has declared closed period from March 24, 2016 to March 30, 2016. Glaxo Smith Kline Pakistan Limited is incorporated in Pakistan as a limited liability company. The company is engaged in manufacturing and marketing of research based pharmaceutical and consumer products. The company is a subsidiary of S.R. One International B.V., Netherlands, whereas its ultimate parent company is GlaxoSmithKline Plc, UK. The stocks of the company are quoted on the Karachi and Lahore Stock Exchanges of Pakistan. The company was created on January 1, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan Private Limited and Glaxo Wellcome Pakistan Limited. Some of the pharmaceutical brands produced by the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and renowned consumer healthcare brands, which include Panadol, Horlicks, Aquafresh, Macleans and ENO. The symbol “GLAXO” is being used by the stock exchanges for the shares of GlaxoSmithKline Pakistan Limited.

Read More »